Variant report

Variant	nsv607944
Chromosome Location	chr7:100329189-100344359
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:69)
CpG islands
(count:305)
Chromatin interactive
region (count:5)
LncRNA
region (count:0)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

(count:69 , 50 per page) page: 1 2

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	ATF3	chr7:100342820-100343137	H1-hESC	embryonic stem cell:	n/a	chr7:100343059-100343070
2	ATF3	chr7:100342909-100343195	H1-hESC	embryonic stem cell:	n/a	chr7:100343059-100343070
3	ATF3	chr7:100342893-100343212	K562	blood:	n/a	chr7:100343059-100343070
4	BACH1	chr7:100342894-100343159	H1-hESC	embryonic stem cell:	n/a	n/a
5	BHLHE40	chr7:100342972-100343060	K562	blood:	n/a	n/a
6	CBX3	chr7:100342793-100343201	K562	blood:	n/a	n/a
7	CEBPB	chr7:100343609-100343978	MCF-7	breast:	n/a	n/a
8	CEBPB	chr7:100343705-100343937	K562	blood:	n/a	n/a
9	CEBPB	chr7:100343788-100343966	HepG2	liver:	n/a	n/a
10	CEBPB	chr7:100342877-100343235	H1-hESC	embryonic stem cell:	n/a	chr7:100343086-100343094
11	CEBPB	chr7:100342881-100343252	IMR90	lung:	n/a	chr7:100343086-100343094
12	CEBPB	chr7:100342869-100343223	K562	blood:	n/a	chr7:100343086-100343094
13	CEBPB	chr7:100343051-100343081	HepG2	liver:	n/a	n/a
14	CEBPB	chr7:100342882-100343246	K562	blood:	n/a	chr7:100343086-100343094
15	CREB1	chr7:100342840-100343272	GM12878	blood:	n/a	n/a
16	CREB1	chr7:100342840-100343218	H1-hESC	embryonic stem cell:	n/a	n/a
17	CTCF	chr7:100334240-100334390	HepG2	liver:	n/a	n/a
18	CTCF	chr7:100329480-100329513	GM13976	blood:	n/a	n/a
19	E2F6	chr7:100342894-100343128	K562	blood:	n/a	chr7:100343086-100343095
20	E2F6	chr7:100342790-100343148	H1-hESC	embryonic stem cell:	n/a	chr7:100343086-100343095
21	EP300	chr7:100340972-100340992	K562	blood:	n/a	n/a
22	FOXA1	chr7:100336911-100337230	HepG2	liver:	n/a	n/a
23	FOXA2	chr7:100336974-100337182	HepG2	liver:	n/a	n/a
24	GABPA	chr7:100342690-100343159	K562	blood:	n/a	n/a
25	HDAC2	chr7:100342822-100343070	H1-hESC	embryonic stem cell:	n/a	chr7:100343006-100343015
26	HEY1	chr7:100342906-100343153	K562	blood:	n/a	n/a
27	HNF4A	chr7:100334443-100334631	HepG2	liver:	n/a	n/a
28	JUND	chr7:100342951-100343181	H1-hESC	embryonic stem cell:	n/a	chr7:100343084-100343093
29	JUND	chr7:100343067-100343071	K562	blood:	n/a	n/a
30	MAX	chr7:100342760-100343165	H1-hESC	embryonic stem cell:	n/a	n/a
31	MAX	chr7:100342791-100343252	K562	blood:	n/a	n/a
32	MAX	chr7:100342803-100343234	ECC-1	luminal epithelium:	n/a	n/a
33	MAX	chr7:100342803-100343261	H1-hESC	embryonic stem cell:	n/a	n/a
34	MAZ	chr7:100342782-100343344	IMR90	lung:	n/a	n/a
35	MYC	chr7:100342990-100343079	K562	blood:	n/a	n/a
36	MYC	chr7:100341368-100341495	H1-hESC	embryonic stem cell:	n/a	n/a
37	NFYB	chr7:100342969-100343182	K562	blood:	n/a	chr7:100343082-100343097 chr7:100343085-100343095 chr7:100343083-100343097 chr7:100343082-100343097
38	NR2F2	chr7:100337909-100338392	K562	blood:	n/a	n/a
39	NR2F2	chr7:100337986-100338300	K562	blood:	n/a	n/a
40	PAX5	chr7:100329892-100330334	GM12891	blood:	n/a	n/a
41	PAX5	chr7:100340199-100340350	GM12878	blood:	n/a	n/a
42	POLR2A	chr7:100335245-100335321	GM12878	blood:	n/a	n/a
43	POLR2A	chr7:100342883-100343165	Gliobla	brain:	n/a	n/a
44	POLR2A	chr7:100334700-100334719	HepG2	liver:	n/a	n/a
45	POLR2A	chr7:100331776-100331843	K562	blood:	n/a	n/a
46	POLR2A	chr7:100342028-100342033	MCF-7	breast:	n/a	n/a
47	POLR2A	chr7:100329493-100329614	H1-hESC	embryonic stem cell:	n/a	n/a
48	POLR2A	chr7:100329481-100329606	H1-hESC	embryonic stem cell:	n/a	n/a
49	POLR2A	chr7:100334504-100334656	HepG2	liver:	n/a	n/a
50	POLR2A	chr7:100342812-100343304	HCT-116	colon:	n/a	n/a

(count:305 , 50 per page) page: 1 2 3 4 5 6 7

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr7:100343083-100343133	HCT-116	colon:	n/a
2	chr7:100330109-100330159	HCPEpiC	choroid plexus:	n/a
3	chr7:100343083-100343133	GM12891	blood:	n/a
4	chr7:100343110-100343160	HRE	kidney:	n/a
5	chr7:100330587-100330637	HCT-116	colon:	n/a
6	chr7:100343110-100343160	SK-N-SH_RA	brain:	n/a
7	chr7:100343083-100343133	NB4	blood:	n/a
8	chr7:100330587-100330637	NH-A	brain:	n/a
9	chr7:100330109-100330159	NHBE	bronchial:	n/a
10	chr7:100343110-100343160	AG10803	skin:	n/a
11	chr7:100330587-100330637	AG04449	skin:	fetal
12	chr7:100343083-100343133	LNCaP	prostate:	n/a
13	chr7:100330872-100330922	HRPEpiC	eye:	n/a
14	chr7:100343083-100343133	AG04450	lung:	fetal
15	chr7:100330109-100330159	GM12892	blood:	n/a
16	chr7:100330109-100330159	SKMC	muscle:	n/a
17	chr7:100343110-100343160	K562	blood:	n/a
18	chr7:100343110-100343160	HAEpiC	amniotic membrane:	n/a
19	chr7:100343110-100343160	T-47D	breast:	n/a
20	chr7:100330109-100330159	BE2_C	brain:	n/a
21	chr7:100330587-100330637	HIPEpiC	eye:	n/a
22	chr7:100330109-100330159	ovcar-3	ovarian:	n/a
23	chr7:100330587-100330637	MCF10A-Er-Src	breast:	n/a
24	chr7:100343110-100343160	AG04449	skin:	fetal
25	chr7:100343110-100343160	HPAEpiC	pulmonary alveolar:	n/a
26	chr7:100343110-100343160	BJ	skin:	n/a
27	chr7:100330109-100330159	Hela-S3	cervix:	n/a
28	chr7:100330109-100330159	IMR90	lung:	fetal
29	chr7:100330872-100330922	GM12892	blood:	n/a
30	chr7:100343083-100343133	HRPEpiC	eye:	n/a
31	chr7:100343110-100343160	HNPCEpiC	eye:	n/a
32	chr7:100330109-100330159	K562	blood:	n/a
33	chr7:100330587-100330637	SK-N-MC	brain:	n/a
34	chr7:100330587-100330637	HRCEpiC	kidney:	n/a
35	chr7:100343083-100343133	SK-N-SH_RA	brain:	n/a
36	chr7:100330872-100330922	SKMC	muscle:	n/a
37	chr7:100343110-100343160	ProgFib	skin:	n/a
38	chr7:100343083-100343133	SKMC	muscle:	n/a
39	chr7:100330109-100330159	HAEpiC	amniotic membrane:	n/a
40	chr7:100343110-100343160	H1-hESC	embryonic stem cell:	embryo
41	chr7:100330587-100330637	GM06990	blood:	n/a
42	chr7:100330109-100330159	PrEC	prostate:	n/a
43	chr7:100343083-100343133	Caco-2	colon:	n/a
44	chr7:100330109-100330159	HCM	heart:	n/a
45	chr7:100330872-100330922	HRE	kidney:	n/a
46	chr7:100343110-100343160	GM12891	blood:	n/a
47	chr7:100343083-100343133	NHDF-neo	bronchial:	n/a
48	chr7:100343110-100343160	GM12892	blood:	n/a
49	chr7:100330872-100330922	PrEC	prostate:	n/a
50	chr7:100330587-100330637	NT2-D1	testis:	n/a

(count:5 , 50 per page) page: 1

No.	Distal block	Cell Line	Cell type
1	chr7:100336156..100338514-chr7:100343827..100346025,2	K562	blood:
2	chr7:100330076..100331647-chr7:100341645..100343390,2	K562	blood:
3	chr7:100164565..100167457-chr7:100344225..100346169,2	K562	blood:
4	chr7:100336156..100338514-chr7:100343827..100346025,2	K562	blood:
5	chr7:100033824..100035649-chr7:100341389..100343074,2	K562	blood:

No data

Variant related genes	Relation type
ZAN	TF binding region
ZAN	CpG island
ENSG00000240211	chromatin interactions
ENSG00000146839	chromatin interactions
ENSG00000160813	chromatin interactions

Extended variants
information (count: 537 )
Associated
traits (count: 95 )

Variant overlapped rSNPs/rCNVs (count:537 , 50 per page) page: 1 2 3 4 5 6 7 ... 11

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs6975957	chr7:100329189-100329190	Weak transcription	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
2	rs560995159	chr7:100329226-100329227	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
3	rs529130372	chr7:100329259-100329260	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
4	rs200782533	chr7:100329360-100329361	Weak transcription Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
5	rs138330523	chr7:100329402-100329403	Weak transcription Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
6	rs562658608	chr7:100329530-100329531	Weak transcription Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
7	rs2406257	chr7:100329567-100329568	Weak transcription Enhancers	TF binding region	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
8	rs373473786	chr7:100329579-100329580	Weak transcription Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
9	rs144073889	chr7:100329601-100329602	Weak transcription Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
10	rs142144640	chr7:100329613-100329614	Weak transcription Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
11	rs142859193	chr7:100329614-100329615	Weak transcription Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
12	rs370314239	chr7:100329615-100329616	Weak transcription Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
13	rs58927259	chr7:100329617-100329618	Weak transcription Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
14	rs199984017	chr7:100329618-100329619	Weak transcription Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
15	rs554315946	chr7:100329733-100329734	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
16	rs527428013	chr7:100329734-100329735	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
17	rs548976275	chr7:100329784-100329785	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
18	rs71555297	chr7:100329870-100329871	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
19	rs71555298	chr7:100329873-100329874	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
20	rs71555299	chr7:100329876-100329877	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
21	rs71555300	chr7:100329891-100329892	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
22	rs71530304	chr7:100329905-100329906	Weak transcription Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
23	rs559512991	chr7:100329920-100329921	Weak transcription Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
24	rs115919587	chr7:100329923-100329924	Weak transcription Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
25	rs566106145	chr7:100329931-100329932	Weak transcription Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
26	rs550420989	chr7:100329940-100329941	Weak transcription Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
27	rs34146549	chr7:100329977-100329978	Weak transcription Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
28	rs397890265	chr7:100329991-100329992	Weak transcription Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
29	rs571850313	chr7:100330038-100330039	Weak transcription Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
30	rs376521161	chr7:100330052-100330053	Weak transcription Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
31	rs2406256	chr7:100330091-100330092	Weak transcription Enhancers	TF binding region	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
32	rs572205854	chr7:100330111-100330112	Weak transcription Enhancers	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
33	rs75714327	chr7:100330142-100330143	Weak transcription Enhancers	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
34	rs111796318	chr7:100330298-100330299	Weak transcription Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
35	rs187192107	chr7:100330324-100330325	Weak transcription Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
36	rs55867001	chr7:100330325-100330326	Weak transcription Enhancers	TF binding region	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
37	rs191648750	chr7:100330483-100330484	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
38	rs111338114	chr7:100330492-100330493	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
39	rs562758934	chr7:100330519-100330520	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
40	rs374394343	chr7:100330586-100330587	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
41	rs184464349	chr7:100330626-100330627	Weak transcription Enhancers	CpG island	1 gene(s)	Overlapped CNVs	n/a
42	rs541066375	chr7:100330648-100330649	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
43	rs564737635	chr7:100330667-100330668	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
44	rs545218672	chr7:100330679-100330680	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
45	rs559074751	chr7:100330680-100330681	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
46	rs530900640	chr7:100330841-100330842	Weak transcription Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
47	rs144843407	chr7:100330842-100330843	Weak transcription Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
48	rs527363136	chr7:100330866-100330867	Weak transcription Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
49	rs188566621	chr7:100330889-100330890	Weak transcription Enhancers	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
50	rs375845408	chr7:100330890-100330891	Weak transcription Enhancers	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a

Variant related diseases (count:95)

Disease	PMID	Source
Basal cell lymphoma	17170743	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Ewing''s sarcoma	21437220	CNVD
Glioblastoma multiforme	21080181	CNVD
Thyroid cancer	19087340	CNVD
Seminomas	18059402	CNVD
Testicular cancer	18059402	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Autism	19415332	CNVD
Medulloblastoma	21979893	CNVD
Pleomorphic xanthoastrocytoma	20730472	CNVD
T-cell lymphomas	19863542	CNVD
Malaria	21533027	CNVD
Melanoma	18172304	CNVD
Renal cell carcinoma	19461508	CNVD
head and neck squamous cell carcinoma	19289630	CNVD
Stenocardia	21860640	CNVD
Vasospasm	21860640	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
Ewing''s sarcoma	17952124	CNVD
Autism	22495311	CNVD
Wilms tumour	21544195	CNVD
Non-small cell lung cancer	21829676	CNVD
Gastric cancer	24379144	CNVD
Glioblastoma multiforme	17002787	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Lissencephaly	21572526	CNVD
Breast cancer	17603634	CNVD
Liposarcoma	21253554	CNVD
Breast cancer	16397240	CNVD
Acute myeloid leukemia	16864856	CNVD
Squamous cell cancer	21044232	CNVD
Non-syndromic sensorineural hearing loss	18471307	CNVD
Astrocytoma	17387387	CNVD
Glioblastoma multiforme	17387387	CNVD
Low-grade fibromyxoid sarcoma	0	CNVD
Oligodendroglial tumors	17285580	CNVD
Endometrial cancer	22040021	CNVD
Burkitt''s lymphoma	18698080	CNVD
Breast cancer	21264507	CNVD
Shwachman-Diamond syndrome	22934832	CNVD
Colorectal cancer	19359472	CNVD
Cutaneous malignant melanoma	17690212	CNVD
Leukemia	17361228	CNVD
Breast cancer	16461572	CNVD
Peripheral t-cell lymphoma	19118030	CNVD
Malignant melanoma	17690212	CNVD
Renal cell carcinoma	18592004	CNVD
Acute promyelocytic leukemia	19109227	CNVD
Multiple myeloma	17550852	CNVD
small cell lung cancer	20016488	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Neurodevelopmental disorder	22521361	CNVD
abortions and stillbirths	19751515	CNVD
Acute lymphoblastic leukemia	21980252	CNVD
Acute myeloid leukemia	20729466	CNVD
Lung cancer	18438408	CNVD
Metanephric adenoma	20802469	CNVD
Prostate cancer	16461572	CNVD
Endometrioid adenocarcinoma	16974079	CNVD
Non-syndromic sensorineural hearing loss	21987784	CNVD
Burkitt''s lymphoma	19759907	CNVD
Malignant melanoma	17260012	CNVD
Myelodysplastic syndrome	21251322	CNVD
Acute myeloid leukemia	21251322	CNVD
Breast cancer	21785460	CNVD
Chronic myeloid leukemia	21384125	CNVD
Bladder cancer	21909424	CNVD
Acute lymphoblastic leukemia	21339820	CNVD
Biliary cancer	19435499	CNVD
Myelofibrosis	22110671	CNVD
Splenic marginal zone lymphoma	21957467	CNVD
Breast cancer	16608533	CNVD
Primary central nervous system lymphoma	21088137	CNVD
Liver carcinoma	19366792	CNVD
T-cell acute lymphoblastic leukemia	19406988	CNVD
Adenocarcinoma	19607727	CNVD
Multiple myeloma	16461302	CNVD
Breast cancer	21858162	CNVD
Emphysema	19352772	CNVD
Effusion lymphoma	18079361	CNVD
Medulloblastoma	17653508	CNVD
Primary mediastinal b-cell lymphoma	17728785	CNVD
Autism	19401682	CNVD
Neuroticism	17667963	CNVD
Breast cancer	21509527	CNVD
Chronic lymphocytic leukemia	22228453	CNVD
Prostate cancer	18632612	CNVD
Urothelial carcinoma	21177765	CNVD
Acute lymphoblastic leukemia	22237106	CNVD
Non-syndromic sensorineural hearing loss	17122850	CNVD
Breast cancer	21364760	CNVD
Cancer	20164919	CNVD
Breast cancer	22522925	CNVD
Non-syndromic sensorineural hearing loss	18451855	CNVD

Chromatin state (count:134 , 50 per page) page: 1 2 3

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr7:100319200-100342800	Weak transcription	Right Atrium	heart
2	chr7:100323800-100334400	Weak transcription	iPS DF 19.11 Cell Line	embryonic stem cell
3	chr7:100325400-100333000	Weak transcription	Liver	Liver
4	chr7:100328800-100329200	Weak transcription	HepG2	liver
5	chr7:100329200-100334400	Enhancers	HepG2	liver
6	chr7:100329600-100331000	Enhancers	Primary B cells from peripheral blood	blood
7	chr7:100329600-100331200	Enhancers	Primary B cells from cord blood	blood
8	chr7:100329800-100330600	Enhancers	GM12878-XiMat	blood
9	chr7:100331400-100331800	Enhancers	Primary hematopoietic stem cells G-CSF-mobilized Female	--
10	chr7:100331400-100331800	Enhancers	Cortex derived primary cultured neurospheres	brain
11	chr7:100331400-100332000	Enhancers	Primary hematopoietic stem cells G-CSF-mobilized Male	--
12	chr7:100331600-100332000	Enhancers	Ganglion Eminence derived primary cultured neurospheres	brain
13	chr7:100333000-100334200	Enhancers	Liver	Liver
14	chr7:100334200-100334400	Flanking Bivalent TSS/Enh	Foreskin Fibroblast Primary Cells skin02	Skin
15	chr7:100334200-100334800	Enhancers	Fetal Intestine Large	intestine
16	chr7:100334400-100334600	Enhancers	iPS DF 6.9 Cell Line	embryonic stem cell
17	chr7:100334400-100334800	Flanking Active TSS	HepG2	liver
18	chr7:100334400-100335000	Genic enhancers	iPS DF 19.11 Cell Line	embryonic stem cell
19	chr7:100334800-100335000	Bivalent/Poised TSS	Foreskin Fibroblast Primary Cells skin02	Skin
20	chr7:100334800-100335000	Active TSS	HepG2	liver
21	chr7:100335000-100336000	Strong transcription	iPS DF 19.11 Cell Line	embryonic stem cell
22	chr7:100335000-100336000	Weak transcription	HepG2	liver
23	chr7:100336000-100337400	Weak transcription	iPS DF 19.11 Cell Line	embryonic stem cell
24	chr7:100336000-100337600	Enhancers	HepG2	liver
25	chr7:100337400-100337800	ZNF genes & repeats	iPS DF 19.11 Cell Line	embryonic stem cell
26	chr7:100337600-100338000	Flanking Active TSS	HepG2	liver
27	chr7:100340600-100342800	Weak transcription	H1 BMP4 Derived Mesendoderm Cultured Cells	ES cell derived
28	chr7:100342000-100342400	Enhancers	Placenta	Placenta
29	chr7:100342400-100343000	Active TSS	Placenta	Placenta
30	chr7:100342600-100342800	Bivalent/Poised TSS	Foreskin Fibroblast Primary Cells skin01	Skin
31	chr7:100342600-100342800	Bivalent/Poised TSS	Fetal Adrenal Gland	Adrenal Gland
32	chr7:100342600-100342800	Active TSS	Fetal Intestine Large	intestine
33	chr7:100342600-100342800	Bivalent Enhancer	Fetal Muscle Trunk	muscle
34	chr7:100342600-100342800	Active TSS	Pancreas	Pancrea
35	chr7:100342600-100342800	Enhancers	Spleen	Spleen
36	chr7:100342600-100343000	Active TSS	Bone Marrow Derived Cultured Mesenchymal Stem Cells	Bone marrow
37	chr7:100342600-100343000	Active TSS	Breast variant Human Mammary Epithelial Cells (vHMEC)	Breast
38	chr7:100342600-100343000	Active TSS	Foreskin Keratinocyte Primary Cells skin02	Skin
39	chr7:100342600-100343000	Active TSS	Esophagus	oesophagus
40	chr7:100342600-100343000	Bivalent/Poised TSS	Fetal Intestine Small	intestine
41	chr7:100342600-100343200	Active TSS	H1 Cell Line	embryonic stem cell
42	chr7:100342600-100343200	Active TSS	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
43	chr7:100342600-100343200	Active TSS	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
44	chr7:100342600-100343200	Active TSS	Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells	embryonic stem cell
45	chr7:100342600-100343200	Bivalent/Poised TSS	Muscle Satellite Cultured Cells	--
46	chr7:100342600-100343200	Bivalent/Poised TSS	Foreskin Fibroblast Primary Cells skin02	Skin
47	chr7:100342600-100343200	Active TSS	Foreskin Melanocyte Primary Cells skin01	Skin
48	chr7:100342600-100343200	Active TSS	Brain Inferior Temporal Lobe	brain
49	chr7:100342600-100343200	Active TSS	Duodenum Mucosa	Duodenum
50	chr7:100342600-100343200	Active TSS	Rectal Mucosa Donor 31	rectum

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links